Your browser doesn't support javascript.
loading
Antibody response to second dose of the BNT162b2 mRNA vaccine in the first 12 weeks in South Korea: A prospective longitudinal study.
Kim, Hyun Jin; Yun, Heon Jeong; Kim, Jungok; Kym, Sungmin; Choi, Qute.
Affiliation
  • Kim HJ; Department of Laboratory Medicine, Chungnam National University School of Medicine, Daejeon, Republic of Korea; Department of Laboratory Medicine, Chungnam National University Sejong Hospital, Sejong, Republic of Korea.
  • Yun HJ; Department of Laboratory Medicine, Chungnam National University Sejong Hospital, Sejong, Republic of Korea.
  • Kim J; Division of Infectious Diseases, Department of Internal Medicine, Chungnam National University School of Medicine, Chungnam National University Sejong Hospital, Sejong, Republic of Korea.
  • Kym S; Division of Infectious Diseases, Department of Internal Medicine, Chungnam National University School of Medicine, Chungnam National University Sejong Hospital, Sejong, Republic of Korea.
  • Choi Q; Department of Laboratory Medicine, Chungnam National University School of Medicine, Daejeon, Republic of Korea; Department of Laboratory Medicine, Chungnam National University Sejong Hospital, Sejong, Republic of Korea. Electronic address: qutechoi@gmail.com.
Vaccine ; 40(3): 437-443, 2022 01 24.
Article in En | MEDLINE | ID: mdl-34953606
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 4_TD Database: MEDLINE Main subject: COVID-19 / BNT162 Vaccine Type of study: Observational_studies Limits: Humans Language: En Journal: Vaccine Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 4_TD Database: MEDLINE Main subject: COVID-19 / BNT162 Vaccine Type of study: Observational_studies Limits: Humans Language: En Journal: Vaccine Year: 2022 Document type: Article